ProfileGDS5678 / 1449518_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 57% 57% 54% 56% 57% 56% 58% 57% 57% 57% 56% 59% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4993957
GSM967853U87-EV human glioblastoma xenograft - Control 23.4704557
GSM967854U87-EV human glioblastoma xenograft - Control 33.4742457
GSM967855U87-EV human glioblastoma xenograft - Control 43.2773854
GSM967856U87-EV human glioblastoma xenograft - Control 53.3533956
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5362157
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4987856
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4879958
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4492957
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4542357
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4491457
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3730256
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5361459
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4556757